Methyl Salicylate 25% Cream

Manufacturer
ALAINA HEALTHCARE PRIVATE LIMITED
Effective date
2025-12-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:21:29

Label at a glance#

ProductMethyl Salicylate
Active ingredientMETHYL SALICYLATE
Label structure11 sections

Indications and uses

Temporarily relieves minor aches and pains of muscles and joints due to: simple backache lumbago arthritis neuralgia strains bruises sprains

Label contents#

Full prescribing information#

Active Ingredient                                               Purpose

OTC - ACTIVE INGREDIENT SECTION

Methyl Salicylate 25%........................................Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves minor aches and pains of muscles and joints due to:

  • simple backache
  • lumbago
  • arthritis
  • neuralgia
  • strains
  • bruises
  • sprains

Warnings

WARNINGS SECTION

For external use only.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes
  • do not use in larger quantities, particularly over raw surfaces or blistered areas
  • do not apply to wounds or damaged skin
  • do not bandage

Stop use and ask doctor if

OTC - STOP USE SECTION

  • allergic reaction occurs
  • condition worsens or does not improve within 7 days
  • symptoms clear up and return within a few days
  • redness, irritation, swelling, pain or other symptoms begin or increase

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Adults and children 2 years and older:apply externally to the affected area up to 3 to 4 times a day
children under 2 years:ask a doctor

Other Information

SPL UNCLASSIFIED SECTION

May be applied under occlusive dressing

Store at 20° C-25° C (68° F-77° F); excursions permitted to 15° C-30° C (59° F-86° F). See USP Controlled Room Temperature.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

C13-14 isoparaffin, cetearyl alcohol, chondrotin sulfate sodium, Ethylhexylglycerin, glucosamide sulfate potassium chloride, glycerin, glyceryl stearate, isostearic acid, laureth-7, PEG-100 stearate, phenoxyethanol, polyacrylamide, propylene glycol, stearic acid, water

OTC - QUESTIONS SECTION

Questions?Call

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Methyl Salicylate 25% Cream
Pain Relieving Cream
Topical Analgesic
2.11 oz (60g)

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
238542methyl salicylate 25 % Topical CreamPSN2
238542methyl salicylate 250 MG/ML Topical CreamSCD2
238542methyl salicylate 25 % Topical CreamSY2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73492-273-60Methyl Salicylate60 g in 1 TUBECREAM602
73492-273-60Methyl Salicylate1 in 1 CARTONCREAM12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73492-27373492-273-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Methyl SalicylateMETHYL SALICYLATEALAINA HEALTHCARE PRIVATE LIMITEDe07c5ebc-5497-4c45-acc5-d12e72e98f3f2025-12-09WarningsExact identifier
ndc (package): 73492-273-60
ndc (product): 73492-273
ndc11 (package): 73492027360
spl id: 4583a826-8742-8083-e063-6394a90a5c25
spl set id: e07c5ebc-5497-4c45-acc5-d12e72e98f3f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.